Equity Overview
Price & Market Data
Price: $1.67
Daily Change: -$0.14 / 8.38%
Daily Range: $1.65 - $1.95
Market Cap: $58,807,968
Daily Volume: 840,448
Performance Metrics
1 Week: -14.80%
1 Month: -8.24%
3 Months: -24.77%
6 Months: -12.11%
1 Year: -54.50%
YTD: -60.98%
Company Details
Employees: 5
Sector: Health technology
Industry: Biotechnology
Country:
Details
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.